We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$419B
1-Year Est. Return
43.02%
This Fund
S&P 500
This Quarter
Est. Return
+9.78%
1 Year Est. Return
+43.02%
3 Year Est. Return
+139.43%
5 Year Est. Return
+185.66%
10 Year Est. Return
+615.14%
AUM
$258B
AUM Growth
+$11.2B
(+4.5%)
Cap. Flow
-$8.74B
Cap. Flow
% of AUM
-3.39%
Top 10 Holdings %
Top 10 Hldgs %
19.2%
Holding
3,329
New
40
Increased
1,011
Reduced
1,986
Closed
159
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Prologis
PLD
|
+$352M |
| 2 |
Merck
MRK
|
+$333M |
| 3 |
NVIDIA
NVDA
|
+$306M |
| 4 |
Atlassian
TEAM
|
+$280M |
| 5 |
Corteva
CTVA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.41B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$331M |
| 3 |
iShares Russell 1000 Growth ETF
IWF
|
+$266M |
| 4 |
Danaher
DHR
|
+$240M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.56% |
| 2 | Healthcare | 14.16% |
| 3 | Financials | 12.95% |
| 4 | Consumer Discretionary | 9.76% |
| 5 | Industrials | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1401
Hims & Hers Health
HIMS
$6.95B
| $11.1M | ﹤0.01% |
1,724,317
-277,378
| -14% | -$1.58M |
|
|
SKX
1402
DELISTED
Skechers
SKX
| $11.1M | ﹤0.01% |
263,496
-20,267
| -7% | -$776K |
|
1403
MKS Inc
MKSI
$20.9B
| $11M | ﹤0.01% |
130,294
-49,911
| -28% | -$4M |
|
1404
Popular Inc
BPOP
$11.2B
| $11M | ﹤0.01% |
165,990
-2,618
| -2% | -$182K |
|
1405
California Water Service
CWT
$3.08B
| $11M | ﹤0.01% |
181,221
+1,155
| +0.6% | +$69.4K |
|
|
VIVO
1406
DELISTED
Meridian Bioscience Inc
VIVO
| $10.9M | ﹤0.01% |
329,146
-103,682
| -24% | -$3.34M |
|
1407
Viridian Therapeutics
VRDN
$2.64B
| $10.9M | ﹤0.01% |
321,466
+218,717
| +213% | +$5.04M |
|
1408
Andersons Inc
ANDE
$2.21B
| $10.9M | ﹤0.01% |
311,797
-49,797
| -14% | -$1.77M |
|
1409
World Kinect Corp
WKC
$1.88B
| $10.9M | ﹤0.01% |
397,554
+163,339
| +70% | +$4.39M |
|
1410
PagerDuty
PD
$880M
| $10.9M | ﹤0.01% |
408,968
-1,975
| -0.5% | -$46.7K |
|
1411
Avis
CAR
$4.84B
| $10.9M | ﹤0.01% |
66,257
-69,059
| -51% | -$13.9M |
|
1412
Cannae Holdings
CNNE
$633M
| $10.8M | ﹤0.01% |
523,531
-50,365
| -9% | -$1.1M |
|
1413
Customers Bancorp
CUBI
$2.78B
| $10.8M | ﹤0.01% |
381,343
-9,435
| -2% | -$294K |
|
1414
Meritage Homes
MTH
$4.76B
| $10.8M | ﹤0.01% |
234,224
-12,698
| -5% | -$514K |
|
1415
Amphastar Pharmaceuticals
AMPH
$843M
| $10.8M | ﹤0.01% |
384,005
-32,602
| -8% | -$947K |
|
1416
CTS Corp
CTS
$1.82B
| $10.8M | ﹤0.01% |
272,875
-12,261
| -4% | -$504K |
|
|
MRTX
1417
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $10.8M | ﹤0.01% |
237,274
+96,877
| +69% | +$6.27M |
|
|
MZTI
1418
The Marzetti Company
MZTI
$3.15B
| $10.7M | ﹤0.01% |
54,443
-3,841
| -7% | -$730K |
|
1419
Lucid Motors
LCID
$2.53B
| $10.7M | ﹤0.01% |
156,886
-1,911
| -1% | -$210K |
|
1420
Hecla Mining
HL
$12.1B
| $10.7M | ﹤0.01% |
1,926,190
-203,379
| -10% | -$1.01M |
|
1421
ePlus
PLUS
$2.29B
| $10.7M | ﹤0.01% |
241,236
-638
| -0.3% | -$29.8K |
|
1422
Choice Hotels
CHH
$4.69B
| $10.7M | ﹤0.01% |
94,695
-47,918
| -34% | -$5.73M |
|
1423
Noble Corp
NE
$7.07B
| $10.7M | ﹤0.01% |
+268,012
| New | +$9.53M |
|
|
CNR
1424
Core Natural Resources Inc
CNR
$4.64B
| $10.7M | ﹤0.01% |
164,076
+34,044
| +26% | +$2.3M |
|
|
AL
1425
DELISTED
Air Lease Corp
AL
| $10.7M | ﹤0.01% |
277,544
+18,683
| +7% | +$672K |
|
Similar funds
VFT
Nuveen's Q4 2022 Portfolio in Review
As of Q4 2022, Nuveen held 3,329 positions worth $258B, up 4.5% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Nuveen withdrew a net $8.74B in Q4 2022, closing 159 positions and reducing 1,986 holdings. Its most notable exit was Twitter, Inc., an estimated $237M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Nuveen opened a new position in Atlassian worth $226M.
- Nuveen's largest Q4 2022 buy was Atlassian: 1,759,716 shares worth $226M.
- Nuveen added most to Prologis in Q4 2022, an estimated $352M increase.
- Nuveen's biggest Q4 2022 reduction was Alnylam Pharmaceuticals, cutting an estimated $3.41B.
- Nuveen fully exited Twitter, Inc. in Q4 2022, selling an estimated $237M.
- Nuveen's ten largest holdings make up 19% of its $258B portfolio in Q4 2022.
- Nuveen opened 40 new positions and closed 159 in Q4 2022.
- Nuveen's portfolio value rose 4.5% quarter-over-quarter to $258B.
Based on Nuveen's 13F filing for Q4 2022, filed 14 Feb 2023.